Novo Nordisk (NVO)

• Market cap: $197B
• 1 day: 0.81%
• 5 days: -0.31%
• 1 month: 8.13%
• 3 months: 18.96%
• 6 months: -9.73%
• Year to date: -14.96%
• 1 year: -36.75%
• 5 years: 13.04%
• 10 years: 60.71%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Employees: 69,500